RT Journal Article
SR Electronic
T1 Protocol for rapid implementation of a SARS-CoV-2 sero-survey during the 2020 COVID-19 pandemic – who, where, how?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.08.21251348
DO 10.1101/2021.02.08.21251348
A1 Smith, Daniel
A1 Mac, Valerie
A1 Yang, Irene
A1 Butts, Brittany
A1 Hecker, Morgan
A1 Howell, J. Christina
A1 Ozturk, Tugba
A1 Pirmohammed, Shama
A1 Huang, Hanfeng
A1 Kippels, Andrea
A1 Brewster, Glenna
A1 Verble, Danielle D
A1 Jacobs, Winnie
A1 Hu, William T.
A1 Wharton, Whitney
YR 2021
UL http://medrxiv.org/content/early/2021/02/10/2021.02.08.21251348.abstract
AB Introduction The 2019 novel coronavirus disease (COVID-19) pandemic has had devastating consequences in the US, yet clinical research on its natural history and transmission outside hospitalized settings has faced tangible and intangible challenges due to uncertainty in testing, case ascertainment, and appropriate safety measures. To better understand temporal evolution of COVID-19 related serological and other immune responses during a pandemic, we designed and implemented a baseline cross-sectional study of asymptomatic community volunteers and first responders in metro-Atlanta before the predicted infection peak in 2020.Methods We recruited healthy community volunteers and first responders for health history, serology, and biobanking. Through an iterative process, we identified one location on our campus and one community location which were accessible, vacant, distant from COVID-19 testing sites, open for social distancing, private for informed consent, and operational for sanitation and ventilation. Research and cleaning supplies were obtained from other researchers and private online vendors due to shortages, and faculty directly participated in consenting and phlebotomy.Results A total of 369 participants completed the study visits over six full and three half days. Over half of Phase 1 (174/299, 58.2%) and Phase 2 (45/70, 64.3%) self-reported as healthcare workers, and there was a high percentage of participants reporting exposure to known COVID-19 cases (48.2% and 61.4%).Conclusions Rigorous prospective clinical research with informed consents and is possible during a pandemic. Effective recruitment for moderately large sample size is facilitated by direct faculty involvement, connections with the community, and non-financial support from colleagues and the institution.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe team would like to thank the Nell Hodgson Woodruff School of Nursing Rapid Response COVID-19 Pilot Grant Award for funding this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Emory University Institutional Review Board 1599 Clifton Road NE, 5th Floor Atlanta, GA 30322 404-712-0720 All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data generated by this study is available from the authors with reasonable request.